Validation of a novel multiple myeloma early relapse score within the WBMT global study

Описание к видео Validation of a novel multiple myeloma early relapse score within the WBMT global study

Meral Beksac, MD, Istinye University Ankara Liv Hospital, Ankara, Turkey, discusses the development of a novel score to predict early relapse in patients with multiple myeloma, highlighting the importance of identifying functional high-risk patients. Dr Beksac discusses the validation of the score in an external cohort using data from the Worldwide Network for Blood and Marrow Transplantation (WBMT) registry, which showed that the score is valuable in both standard and high-risk patients. This interview took place at the 66th ASH Annual Meeting and Exposition, held in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Комментарии

Информация по комментариям в разработке

Похожие видео